| Indolactam V | Ki | 5.5 [1], 3770.0 [2] |
| Balanol | IC50 | 3.0 [1], 20.0 [2], 22.0 [3] |
| Balanol analog 4 | IC50 | 4.0 [1] |
| Balanol analog 5 | IC50 | 0.6 [1], 1.0 [2] |
| 8-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 119.9 [1], 120.0 [2], 10000.0 [3] |
| 2-[2,6-Dihydroxy-4-[3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 3.0 [1], 20.0 [2], 100.0 [3] |
| Sotrastaurin | IC50 | 6.1 [1] |
| 8-Octyl-benzolactam-V9 | Ki | 140.0 [1], 144.0 [2], 10000.0 [3] |
| Staurosporine | IC50 | 5.0 [1] |
| Phorbol 12,13-dibutyrate | Ki | 0.95 [1], 10.2 [2] |
| (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 4.4 [1] |
| N'-(3-Pyridin-4-yl-2,6-naphthyridin-1-yl)ethane-1,2-diamine | IC50 | 5.0 [1] |
| (2S,5S)-8-Decyl-5-(hydroxymethyl)-1-methyl-2-propan-2-yl-2,4,5,6-tetrahydro-1,4-benzodiazocin-3-one | Ki | 6.4 [1], 2489.0 [2] |
| 2-Methyl-N~1~-[3-(Pyridin-4-Yl)-2,6-Naphthyridin-1-Yl]propane-1,2-Diamine | IC50 | 9.0 [1] |
| 3-(1H-Indol-3-yl)-4-[3-(4-methylpiperazin-1-yl)naphthalen-1-yl]pyrrole-2,5-dione | IC50 | 25.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 0.6 [1], 1.0 [2] |
| 5-Hydroxymethyl-2-isopropyl-1-undecyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 189.0 [1], 6330.0 [2] |
| (10S,13S)-13-(Hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4(15),5,7-tetraene-11-thione | Ki | 20.6 [1], 2160.0 [2] |
| 7-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 111.0 [1], 4250.0 [2] |
| 9-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 37.0 [1], 1590.0 [2] |
| 2-[2,6-Dihydroxy-4-[[2-[(4-hydroxybenzoyl)amino]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 2800.0 [1] |
| [2-[(4-Hydroxyphenyl)methyl]cyclopentyl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 40.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-[(4-hydroxyphenyl)methyl]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-(4-hydroxyphenoxy)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1] |
| 2-[2,6-Dihydroxy-4-[4-[(4-hydroxyphenyl)methyl]pyrrolidin-3-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 20.0 [1], 4300.0 [2] |
| [4-[(4-Hydroxyphenyl)methyl]pyrrolidin-3-yl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 50.0 [1], 500.0 [2] |
| [(1R,2R,6S,10S,11R,13S,14R,15R)-13-Butanoyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] butanoate | Ki | 0.35 [1], 14.9 [2] |
| 2-[2,6-Dihydroxy-4-[(1R,2R)-2-[(4-hydroxybenzoyl)amino]cycloheptyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 60.0 [1] |
| Balanol analog 3 | IC50 | 80.0 [1], 90.0 [2] |
| 2-[2,6-Dihydroxy-4-[(3R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 3.0 [1], 22.0 [2] |
| Bisindolylmaleimide i | IC50 | 10.0 [1] |
| Alvocidib | IC50 | 45000.0 [1] |
| Enzastaurin | IC50 | 400.0 [1] |
| Ruboxistaurin | IC50 | 52.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Purvalanol B | IC50 | 100000.0 [1] |
| Purvalanol A | IC50 | 100000.0 [1] |
| Aplysiatoxin | Ki | 0.36 [1] |
| Gsk-690693 | IC50 | 2.0 [1] |
| Debromoaplysiatoxin | Ki | 0.11 [1] |
| Rac-syn-Balanol | IC50 | 22.0 [1] |
| JNK Inhibitor VIII | Ki | 8300.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 3.5 [1] |
| N-Cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-yl)methylamino)benzamide | IC50 | 40000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 8300.0 [1] |
| 5-(3,4-Dimethoxyphenyl)-4-(1H-indol-5-ylamino)nicotinonitrile | IC50 | 16350.0 [1] |
| 4-(4-Methyl-1H-indol-5-ylamino)-5-(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)nicotinonitrile | IC50 | 450.0 [1] |
| Unii-09RR39UU4V | IC50 | 35000.0 [1] |
| Meridianin E | IC50 | 1300.0 [1] |
| 3-(1-Methyl-1H-indol-3-yl)-4-(1-piperidin-4-yl-1H-indol-3-yl)-pyrrole-2,5-dione | IC50 | 200.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 8300.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 8300.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 8300.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 8300.0 [1] |
| 3-(1H-Indol-3-yl)-4-(2-piperazin-1-ylquinazolin-4-yl)pyrrole-2,5-dione | IC50 | 1.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| 4-Methyl-N-(1,2-oxazol-3-yl)-3-[(1-phenylpyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | IC50 | 40000.0 [1] |
| 2-[3-[(Dimethylamino)methyl]phenyl]-4-[(4-methyl-1H-indol-5-yl)amino]thieno[2,3-b]pyridine-5-carbonitrile | IC50 | 62.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 98.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 1000.0 [1] |
| 1-Piperazin-1-yl-3-pyridin-4-yl[2,6]naphthyridine | IC50 | 6.0 [1] |
| (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-16,16-dimethyl-3-(4-phenylbutyl)-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 12.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| (1R,3R,4R,5S,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-4,16,16-trimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 0.45 [1] |
| Acyclic Balanol Analog 16b | IC50 | 35000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 3-[1-(1-Benzylpiperidin-4-yl)indol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 500.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3R,4R)-3-[(4-hydroxybenzoyl)amino]oxepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3S,4R)-3-[(4-hydroxybenzoyl)amino]thiepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 100.0 [1] |
| 2-[2,6-Dihydroxy-4-[[(3R,4R)-3-[(4-hydroxybenzoyl)amino]-1-azabicyclo[3.2.2]nonan-4-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 26.0 [1] |
| 3-(1H-Indol-3-yl)-4-[3-(4-methylpiperazin-1-yl)isoquinolin-1-yl]pyrrole-2,5-dione | IC50 | 6.2 [1] |
| 2-[4-[(1R,2R,4S)-4-(Aminomethyl)-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonyl-2,6-dihydroxybenzoyl]-3-hydroxybenzoic acid | IC50 | 3.0 [1] |
| [(1R,3S,7S,8E,11S,12S,13E,17R,21R,23S)-11,21-Dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate | Ki | 23.5 [1] |
| (18S)-18-(Hydroxymethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 300.0 [1] |
| 2-[2,6-Dihydroxy-4-[(1R,2R,4S)-2-[(4-hydroxybenzoyl)amino]-4-(hydroxymethyl)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 2.0 [1] |
| 3-(1-Benzothiophen-3-yl)-4-[1-[3-(dimethylamino)propyl]indol-3-yl]pyrrole-2,5-dione | IC50 | 293.0 [1] |
| 2-[4-[(1R,2R,4R)-4-Amino-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonyl-2,6-dihydroxybenzoyl]-3-hydroxybenzoic acid | IC50 | 3.0 [1] |
| 2-[2,6-Dihydroxy-4-[(1R,2R,4R)-4-hydroxy-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 4.0 [1] |
| (18S)-18-(Aminomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 240.0 [1] |
| 2-[2,6-Dihydroxy-4-[(1R,2R,4R)-2-[(4-hydroxybenzoyl)amino]-4-(hydroxymethyl)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 20.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3S,4S)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 260.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3S,4R)-3-[(4-hydroxybenzoyl)amino]-1,1-dioxothiepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 800.0 [1] |
| N-[[(18S)-3,5-Dioxo-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaen-18-yl]methyl]benzenesulfonamide | IC50 | 1900.0 [1] |
| (18S)-18-(Methylaminomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 31.0 [1] |
| (18S)-18-(Morpholin-4-ylmethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 1700.0 [1] |
| (18S)-18-[(4-Methylpiperazin-1-yl)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 2000.0 [1] |
| (18S)-18-[(Benzylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 2500.0 [1] |
| 2-[4-[(1R,2R,4R)-4-(Aminomethyl)-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonyl-2,6-dihydroxybenzoyl]-3-hydroxybenzoic acid | IC50 | 3.0 [1] |
| Tert-butyl 4-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]piperidine-1-carboxylate | IC50 | 8000.0 [1] |
| 3-[1-(1-Benzylpyrrolidin-3-yl)indol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 42.0 [1] |
| 3-(2-Chloro-6-dimethylaminomethyl-naphthalen-1-yl)-4-(1-methyl-1H-indol-3-yl)-pyrrole-2,5-dione | IC50 | 30.0 [1] |
| 3-[2-Chloro-7-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione | IC50 | 316.0 [1] |
| 3-[6-(Aminomethyl)naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 308.0 [1] |
| 3-[2-Chloro-6-[(dimethylamino)methyl]naphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione | IC50 | 7.2 [1] |
| 3-[7-(Aminomethyl)-2-methylnaphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 316.0 [1] |
| 3-[2-Chloro-7-[(4-methylpiperazin-1-yl)methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 316.0 [1] |
| 3-[2-Chloro-7-[(propan-2-ylamino)methyl]naphthalen-1-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 182.0 [1] |
| 3-[7-(Aminomethyl)-2-methylnaphthalen-1-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione | IC50 | 316.0 [1] |
| Ruboxistaurin mesylate | IC50 | 52.0 [1] |